chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient DOB 05/21//2021 received the Janssen vaccine lot # 1821286 exp 10/21/2021 on 09/22/2021 at 11:14am from foot team. At 11:40am the patient was sitting on a chair coloring and said ?My stomach hurts.?  She rated the pain a 5 out of 10. RN asked the patient to describe the pain and asked if it was sharp or dull.  The patient said ?It feels like pain from my ulcers.? The patient said she did not feel the pain before receiving the vaccine. She said she had not had pain from her stomach ulcers in several months and was not taking any medication.   She was alert and oriented x 4. Her skin was dry and the color was appropriate for ethnicity. The patients breathing was regular and unlabored. She denied a history of mental or physical health diagnosis other than stomach ulcers.  She said she was not taking any medication at all.  The patient said she did not feel like she had to vomit or have a bowel movement.  She denied feelings of dizziness or lightheadedness.  At 11:42am the patient said ?The pain is going away.  I think I was just feeling nervous about the vaccine?  and rated the pain a 2 out of 10 on the pain scale.  At 11:45am RN took the patient's vital signs. The patient's blood pressure was 112/68, heart rate 98, respiratory rate 16, Spo2 99% and she said the pain was ?all better.? The patient was educated to seek medical care if the pain returned or other symptoms arose.  The patient agreed to seek care if needed and then stood up and walked away with a steady gait.
I can't get feeling myself; feeling sick; having dizziness, lightheadedness; pain in the stomach; tired; head is going around; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age  (Age: 87; Unit: Unspecified) received first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on an unspecified date for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated that she had the covid vaccine first dose on a Monday and after the shot she had been feeling sick (onset date not reported). She further stated "I can't get feeling myself, having dizziness, lightheadedness, pain in the stomach, feeling sick, tired, head is going around." She wanted to know if that was due to the vaccine. The events were considered as non-serious by the reporter. Patient wanted to know if she should take the second dose. The outcome of the events was unknown.  Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.
PATIENT RECEIVED MORE THAN RECOMMENDED DOSES OF THE COVID-19 VACCINE. THE MODERNA SERIES WAS ADMINISTERED ON 2/3/2021 AND 3/3/2021, THEN THE JANSSEN VACCINE WAS ADMINISTERED ON 4/1/2021.
Muscle Aches; General Malaise; Fatigue; Chicken pox style rash on trunk; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 13:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks prior to vaccination included levothyroxine sodium (SYNTHROID) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 23:30, the patient experienced muscle aches, general malaise, fatigue, chicken pox style rash on trunk. All began around ten hours after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events muscle aches, general malaise, fatigue, chicken pox style rash on trunk was resolved on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
I noticed my heart rate was very high and bounding, and I felt very shaky. I took my heart rate at home with a pulse oximeter and it was 150bpm. I went to the emergency room where they did an EKG, labs, and chest xray; all were within normal limits. I was observed for a few hours and sent home.
Pt with difficulty speaking, elevated blood pressure 189/127, and  headache predominately on the right side. Pt able to speak 5 minutes post vaccine. EMS called for transport to emergency department for evaluation.
Left upper arm painful, swollen, temperature 98.3, and headache. Tdap left deltoid 1-9-07. Admitted to hospital 1-13-07 temperature 101.
pt recv vax 1OCT96 & arm started aching between elbow & shoulder the same day recv vax;pt reported arm feels like there is something still there because arm still aches four mo later;this case was reported by consumer;
2nd dose given 17 days after 1st dose.  offender denies adverse reactions.
30 minutes after vaccination, pt reported mild L arm tingling/numbness to check out desk and was observed by this RN for a few minutes. Denied dyspnea, SOB, itching, dizziness. Pt AOx4, NAD. Brief neuro exam normal. CMS intact to all extremities. Education given r/t f/u with PCP for ongoing/persistent s/s and going to ER for new/worsening s/s. Pt and wife verbalized understanding and departed to get lunch. Approx 1hr later, pt returned with spouse c/o throat irritation/cough. Pt reports that this is new but later does acknowledge a hx of seasonal allergies. Pt also reports that this is what his throat feels like when he has been stung by wasps in the past but denies a hx of anaphylaxis or needing IV medications or e
Perspiring; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Perspiring) and HEADACHE (headache) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Perspiring) and HEADACHE (headache). At the time of the report, HYPERHIDROSIS (Perspiring) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Had vaccines on 3/29/01 and on 3/30/01 began with fever and lethargy. On 3/31/01, fever and lethargy continued and had an episode of choking with her eyes rolling back into her head. Seen at hospital on 3/31/01. Septic work-up done. Had a dose of Rocephin there then again in our office. All labs were negative.
Started immediately w tingling and numbness in L arm (side of injection) and within a few hours developed back pain, then L leg pain then R leg pain.   Headache was worse than baseline.  Numbness improved with hot shower but Ibuprofen helped muscle pain minimally.
Covid arm 24 hours after vaccine. Still have it 3 days later Fatigue 24 hours after vaccine. Still have it 3 days later.  Muscle aches 24 hours after vaccine. Still have it 3 days later
Patient developed 105 degree fever which would not go down, experienced severe chills and shaking and developed bruises.  She also had 2 seizures, and had been seizure free for over two years.
Information has been received from a physician concerning a 4 year old male with asthma, no allergies, and a history of a twenty-seven week gestational birth, who on 07-MAR-2008 was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant suspect therapy included a dose of varicella virus vaccine live (MSD). Other concomitant therapies included a dose of HAVRIX, a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (unspecified), a dose of poliovirus vaccine inactivated (unspecified) and montelukast sodium (MSD). On 07-MAR-2008, the patient developed hives, welts, and rashes on his back that were very painful. The patient sought unspecified medical attention. It was reported that the patient had four out these five vaccines in the past. The only vaccine the patient had not had before was HAVRIX. At the time of this report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested. 05/29/09 This is in follow-up to report(s) previously submitted on 5/30/2008. Follow-up information received 13-MAY-2008: On 07-MAR-2008 at 14:00 hours the patient was vaccinated subcutaneous in the "L" with a second dose of MMR II (lot# 656949/1310U) and subcutaneous in the "R" with a second dose of VARIVAX (Oka/Merck) (MSD) (lot # 659932/1790U). The patient has an allergy to BACTRIM. On 07-MAR-2008 at 17:00 hours the patient developed a rash on the face, neck and arms for 7 days with an itch that was diagnosed as urticaria. The patient was treated with BENADRYL as needed. On 17-MAR-2008 the patient recovered from hives, welts and rashes on the back, face, neck and arms that itched. Additional information has been received from a physician concerning a 5 year old male with asthma and allergies, who on 07-MAR-2008, two to three hours after vaccinations, experienced rash on face, arms and neck, with itching and was diagnosed with urticaria. The patient recovered within one week. There was no illness at time of vaccination. Suspect therapy included the second dose of VARIVAX (MSD), the fifth dose of DAPTACEL (lot # C2765AA) in the left deltoid, the fourth dose of IPOL (lot # Z0548) in the right deltoid and the first dose of HAVRIX (lot # AHAVB253AA) in the left deltoid. Additional information is not expected.
1/26 - fever; swelling  - tylenol 650  1/27 - fever;  swelling  - tylenol 650 1/28 - swelling - 2 tylenol; 200 mg aspirin; ice pack
Mild fever/chills 6 hours after injection -. arm soreness after injection increasing in intensity.  Take one 500 mg Tylenol tablet for fever. Morning following injection left arm was not usable due to pain and soreness.  Second day after injection arm still sore and of limited use.  Day three arm still sore but usable. Day four most adverse reactions gone
Initial case was received on 25 March 2010 from a healthcare professional. A 46 year old female patient received an injection (route and site not reported) of Influenza A H1N1 2009 Monovalent Vaccine - Preservative (lot number UP073AA) on 18 January 2010. Approximately one month later, on approximately 25 February 2010, the patient experienced left ear itching which then progressed to numbness in ear that spread to neck, shoulder, feet, legs and abdomen. The preliminary diagnosis was transverse myelitis. The patient is being treated daily with 1000 mg intravenous (IV) prednisolone. The patient had no illness at the time of the vaccination and no vaccinations within the 4 weeks prior. She had no adverse event following prior vaccinations. She had no known allergies and no pre-existing medical conditions. Concomitant medications were not reported. At the time of this report, the patient had not recovered. Documents held by sender: None.
Mild dizziness; The initial safety information received was reporting only non-serious adverse drug reaction, Upon receipt of follow-up information on 19Oct2021, this case now contains serious adverse reaction. Information processed together.  This is a spontaneous report from a contactable consumer (patient) and a physician. A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at the age of 50-year-old), dose 1 via an unspecified route of administration, administered in arm left on 06Jun2021 17:00 (Batch/Lot Number: EW0202) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included high blood pressure, heart palpitations, Meniere's disease and COVID-19 prior vaccination; HTN (Hypertension) from 2012 and ongoing; ADD (Attention deficit hyperactivity disorder) from 2006 and ongoing; and contraception use. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for attention deficit hyperactivity disorder from 2006 and ongoing; amlodipine besilate (NORVASC) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide taken for hypertension from 2012 and ongoing; ethinylestradiol, etynodiol diacetate (KELNOR) taken for contraception from 2006 and ongoing; amlodipine taken for hypertension from 2012 and ongoing. The patient previously took amoxicillin and experienced allergies. The patient was not pregnant. The patient had no other vaccines in four weeks. The patient had not been tested for COVID since vaccination. The patient experienced mild dizziness on Jun2021 with outcome of recovering. The patient underwent lab tests and procedures which included blood grouping (ABORh): A+ on 09Jul2021; COVID Igg/ COVID Ab Igg on 09Jul2020 and on 28Jul2020 were negative; COVID Igg/COVID Ab Igg on 05Jan2021 was positive (Units: 1.47) and on 20Apr2021 was positive (Units: >10.0). It was mentioned that the patient had mild dizziness for the first 2 days after each vaccine. Seriousness Criteria: Persistent/ significant/disability /incapacity. AE required visit to physician office. The reporting physician considered that the Pfizer product had a casual effect to the adverse event. Therapeutic measures were taken as a result of mild dizziness with Meclizine.   Follow-up attempts are completed. No further information is expected.; Sender's Comments: Based on temporal relationship the possibility of causal association between the event dizziness and the suspect drug BNT162B2 cannot be excluded.    The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
The day after I received the first shot, my stomach began to hurt a lot.  Food quiets it down for a while, then it starts back up again.  Wednesday night, March 31st, I threw up.  During the week, it slowly began to get better, and I had 2 days with no problems,   but last night,( early this morning), it started back up again.
This case was reported by a other health professional via call center representative and described the occurrence of local reaction in an unspecified number of adult patients who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced local reaction and pain. On an unknown date, the outcome of the local reaction and pain were unknown. It was unknown if the reporter considered the local reaction and pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. The health coach reported to the GSK sales representative that they have had patients that have experienced local reactions to the SHINGRIX vaccine including that it was hurt really bad. No additional details were available.
Starting Friday night, I got a bad sore throat. I was extremely stuffy the next day. And sore throat was worsening. I went to the doctor at the local health center. Tested for COVID-19, negative result. Stuffy, ear clogged, and I've been coughing. I started to get better yesterday and now I'm feeling worse again. I have been taking Mucinex and Sudafed and Claritin
Pfizer administered an hour past the 6 hour expiration window after vial is punctured.  Called Pfizer Medical team: Physical Stablility testing shows that the product maintains quality measure at 6 hours up to 18 hours at 2-38 C per
8.5cmX10cm erythema rash on left anterior thigh. Appeared 24 hours after vaccinations received for DTaP, IPV, MMR.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2022 at 14:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "HTN" (unspecified if ongoing), notes: Other medical history: HTN. The patient's concomitant medications were not reported. The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Past drug history included: Hydrocodone, reaction(s): "Known allergies: Hydrocodone". The patient had no other medications in 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid start and stop in Jul2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the Reported events and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Client states approximately ten days after receiving Zostavax vaccine, she had severe muscle cramps 5 to 10 times a day in the following areas of her body; the lower rib cage, abdomen, back, arms and legs. No c/o GI symptoms. Denies taking medication for muscle cramps. She states muscle cramps have decrease one to two times daily and cramps are not as painful or severe. Presently, client is vacationing and will return home on March 3, 2009.
Began with pruritis arms/legs 20min post vaccine. Today (next day). Erythematous, irregular rash on face with mild swelling around eye. Prednisolone taper given.
Momentary sharp shooting pain in center of lower back; pain in upper left thigh, near left hip; Painful to arise from sitting position for 4 days.; This is a spontaneous report from a contactable consumer (Patient). A 74-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL9262, Expiration date: unknown) via an unspecified route of administration at left arm on 20Jan2021 at 13:00 at single dose for COVID-19 Immunization. Medical history included CAD with 1 stent, history of cardiac arrest 2014, degenerative disc disease and allergies to Penicillin, Ceftin, Erythromycin. Concomitant medications included Lipitor, Levothyroxine, Metoprolol, aspirin (81 mg). Prior to vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not tested for COVID-19 since the vaccination. On 20Jan2021 16:00 (24-hour clock), patient experienced momentary sharp shooting pain in center of lower back, followed about an hour later by pain in upper left thigh, near left hip, painful to arise from sitting position for 4 days. Only comfortable in standing or lying on back in bed, it was resulted in doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment for events, but patient was self-treated with Acetaminophen. Outcome for the events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
During the night I woke up to all my joints feeling like they were on fire. The next morning it got better but then I had a lot of dizziness. I have a sore arm, which I expected.
pt recvd vax & devel f w/ 104.5 t; pt devel swelling, red rash on LL about 10cm x 10cm;
A mother reported that her 4 month old son, with a history of reflux problems, received his second doses of Prevnar, IPV, DTap and haemophilus b conjugate vaccines on 25 FEB 2002. That same day, the infant developed an increase in reflux that led to aspiration. He was treated with Cefzil. The mother stated that the physician believes that the reactions may be the result of an allergy to the ingredients in any of the vaccines received.
swollen lymph node left behind right ear; This spontaneous case was reported by a patient and describes the occurrence of LYMPHADENOPATHY (swollen lymph node left behind right ear) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history was reported.     On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node left behind right ear). At the time of the report, LYMPHADENOPATHY (swollen lymph node left behind right ear) had not resolved. Not Provided          Concomitant medication and treatment information were not reported.  Action taken with mRNA-1273 in response to the event was Not Applicable
I felt totally fine prior to vaccination. 3 hours after receiving the vaccine, cough and some wheezing developed.  It was uncomfortable to swallow, like a big lump was in my throat.  I developed shaking chills, purulent drainage from my eyes.  I also became nauseous and vomited.  I used Maxair inhaler and Benadryl for the tight cough and wheeze.  Fortunately, symptoms were relieved after several hours and I opted not to be seen for treatment.
Information has been received from a nurse practitioner concerning a 26 year old female who was vaccinated with 3 doses of GARDASIL series at another office. The patient had abnormal Pap smear on 21-DEC-2009, and tested positive for HPV post vaccination. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. This is one of several reports received from the same source. Additional information is not expected.
Dizziness, which started about 1pm (vaccination was given about 11:45 am, Mon. May 8, 2006. Very worrisome as I had to be very careful when I walked for fear of falling. Serious condition until about 3am Wednesday morn. Then sort of became light-headed throughout rest of Wednesday. It appears to be wearing off now(Wed. evening @ 6:30 pm).
Pfizer-BoiNTech COVID-19 Vaccine EAU Rash all over. Taking Zertec.